Papers
7
Total Citations
109
H-Index
5
About
Dr. Guanghua Liu is a pioneering urologic surgeon whose research centers on advancing robotic-assisted surgery, particularly for kidney and prostate cancers. A leading figure in the clinical evaluation of the KangDuo Surgical Robot (KD-SR)—a domestically developed Chinese robotic system—Dr. Liu has spearheaded landmark trials comparing its safety and efficacy to the established da Vinci system. His most impactful work, a double-center randomized controlled noninferiority trial published in 2022 (54 citations), demonstrated that the KD-SR is a viable alternative for robot-assisted partial nephrectomy, a finding with profound implications for expanding access to cost-effective robotic surgery. Further studies have confirmed the feasibility of the KD-SR for partial adrenalectomy and radical prostatectomy, with his 2024 prospective trial (8 citations) reinforcing its potential. Dr. Liu has also contributed to optimizing perioperative care through a systematic review on enhanced recovery after surgery (ERAS) for robotic prostatectomy (10 citations). With over 100 cumulative citations, his work is not only advancing surgical technology but also shaping global conversations on surgical equity and innovation in urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7